NASDAQ:ELOX

Eloxx Pharmaceuticals Stock Predictions

Healthcare > Biotechnology

Buy ELOX

*Your capital is at risk

$0.370

+0 (+0%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

ELOX Prediction Chart

ELOX Predictions History

Latest community submissions for ELOX.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Dec 18, 2020	$3.63 -99.80%	$4.16	V	87.26%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for ELOX with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT ELOXX PHARMACEUTICALS INC.

Eloxx Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing ribosome modulation for the treatment of rare and ultra-rare premature stop codon diseases. Its lead investigational drug product candidate is ELX-02, which is in Phase 2 clinical trial for the treatment of cystic fibrosis and nephropathic cystinosis patients with diagnosed nonsense mutations. The company also develops various preclinical programs for t...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by